Bill > S1160

This bill establishes new regulations for health care practitioners selling medical devices and products directly in their offices, aiming to protect patients from potential conflicts of interest and undue pressure. It defines key terms like "health care practitioner," "in-office sale," and "medical device" (excluding prescription items covered by insurance). The bill mandates that practitioners disclose any financial interests they or their family have in the sale, inform patients about alternative purchase options and market prices, ensure the product offers a reasonable therapeutic benefit, provide clear information on benefits and risks, and prominently display a notice that patients are not obligated to buy. Violations can result in fines of up to $5,000 per offense, restitution to patients, or suspension or revocation of the practitioner's license, with enforcement handled by the relevant professional licensing board and the Department of Public Health for financial penalties. An exemption exists if a patient's health or safety would be immediately endangered by having to obtain the device or product elsewhere.